Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nanometer antibody targeting norovirus protein and application thereof

A nanobody and protein technology, applied in the field of antibody technology and biomedicine, can solve the problems of high immunogenicity, long production cycle, vacancy of nanobody, etc.

Active Publication Date: 2022-07-12
广州明药科技有限公司
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, norovirus-specific antibodies prepared by the above methods are traditional monoclonal antibodies, and monoclonal antibodies have the following disadvantages: long production cycle, high preparation cost, High immunogenicity, difficult to be cleared in the body, weak tissue penetration ability
Nanobody is a new type of antibody material, which is still in the development stage. At present, there are few nanobody products on the market, and nanobody products targeting norovirus are even more vacant.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nanometer antibody targeting norovirus protein and application thereof
  • Nanometer antibody targeting norovirus protein and application thereof
  • Nanometer antibody targeting norovirus protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1. Panning of phage display library

[0022] According to the method of binding, washing, elution and amplification, the phage display library was subjected to affinity panning, and the Norovirus capsid protein VP1 antigen was used as the antigen for panning targeting Norovirus Nanobodies, and the Alternate blocking with no blocking and 5% milk to reduce nonspecific adsorption. The specific steps of panning are as follows. Add 100 μL of viral protein antigen at a concentration of 10 μg / mL (1 μg / well) to the wells of the eight-continuous-well enzyme-labeled strip, and coat at 37 °C for 2 hours. The supernatant was discarded, and the enzyme-labeled strip was washed 5 times with 0.05% PBST. For blocking, add 200 μL of 5% milk to each well and block for 2 hours at 37 °C. The blocking solution was discarded, and the ELISA strip was washed 5 times with 0.05% PBST. Add 100 μL of phage library suspension to each well (the volume is 8×10 9 pfu, titer of 1×10 9 cf...

Embodiment 2

[0023] Embodiment 2. Identification of positive clones

[0024] A single colony was randomly picked from the titered plate for phage rescue and purification, and then positive clones were identified by ELISA. Specific steps are as follows. Add 100 μL of viral protein antigen at a concentration of 10 μg / mL (1 μg / well) to the wells of the eight-continuous-well enzyme-labeled strip, and coat at 37 °C for 2 hours. The supernatant was discarded and the ELISA strip was washed 5 times with PBST. Add 200 μL of 5% milk to each well, and make another strip as a negative control, and block at 37 °C for 2 hours. The enzyme-labeled strips were washed 5 times with PBST. Add 100 μL of amplified monoclonal phage suspension to each well, and incubate with shaking at room temperature for 1 hour. Plates were washed 5 times with PBST. Add 100 μL of mouse anti-human influenza hemagglutinin (HA) primary antibody to each well, and incubate with shaking at room temperature for 1 hour. Plates we...

Embodiment 3

[0025] Example 3. Fusion of Nanobodies Nor2 and Nor3 with Histidine Tag and Human Influenza Virus Hemagglutinin Tag

[0026] In the phage display library, the nanobody is fused to the capsid protein P3 of the M13 phage and displayed on the surface of the phage particle. We cut the base sequences of the obtained Nanobodies Nor2 and Nor3 into gene fragments with restriction enzymes NdeI and XhoI, inserted them into the pET23a plasmid, and introduced a histidine tag and human influenza virus blood into the C-terminus of the Nanobodies. The lectin tag facilitates the separation, purification and identification of recombinant proteins using nickel columns. The C-terminal amino acid sequence of the fusion protein of Nanobodies Nor2 and Nor3 is: GQAGQHHHHHHGAYPYDVPDYALEHHHHHH*.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

Norovirus is a virus capable of causing acute gastroenteritis. The invention discloses two nano antibodies targeting norovirus capsid protein, and expression, purification and identification of the two nano antibodies. The nanobody targeting the norovirus can be used for environmental monitoring of the norovirus and clinical diagnosis and treatment of norovirus infection.

Description

technical field [0001] The invention relates to the field of antibody technology and biomedicine, in particular to the monitoring of norovirus transmission and the diagnosis and treatment of norovirus-infected diseases. Background technique [0002] Norovirus was discovered by Kapikian in 1972 by using immunoelectron microscopy in the feces of patients with acute gastroenteritis that broke out in Norwalk, USA in 1968. Today, norovirus has become the main cause of nonbacterial acute diarrhea, and 60% to 90% of all nonbacterial diarrhea outbreaks in the United States each year are caused by norovirus. In Chinese children with diarrhea under the age of 5, the detection rate of norovirus is about 15%. But so far, there is no specific drug on the market that can effectively treat norovirus infection. Therefore, research on a rapid and accurate early detection method for norovirus has far-reaching significance for the prevention and treatment of the virus. [0003] Antibodies a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/10G01N33/569
CPCC07K16/10G01N33/56983C07K2317/565G01N2333/08Y02A50/30
Inventor 叶其壮王梓杨白晓康陈锦德肖利群
Owner 广州明药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com